1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Advanced Solid Neoplasms: new trials by email Literature Review of Advanced Solid Neoplasms trials Research Report on Advanced Solid Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer (MK-7339-002 / LYNK-002) Olaparib - Advanced Solid Neoplasms | Phase 2 | Active not recruiting | Merck Sharp & Dohme LLC | 329 | 2018-12-12 | 2026-08-14 |
olaparib (1)
Argentina (1) · Australia (1) · Canada (1) · Colombia (1) · Denmark (1) · France (1) · Guatemala (1) · Ireland (1) · Israel (1) · Italy (1) · Japan (1) · Mexico (1) · Peru (1) · Romania (1) · Russia (1)
2018 (1)